Skip to main content
UCB logo

UCB — Investor Relations & Filings

Ticker · UCB ISIN · BE0003739530 LEI · 2138008J191VLSGY5A09 BR Manufacturing
Filings indexed 2,023 across all filing types
Latest filing 2024-06-07 Transaction in Own Shar…
Country BE Belgium
Listing BR UCB

UCB is a global biopharmaceutical company that focuses on creating solutions for people living with severe diseases, primarily in the fields of neurology and immunology. The company's core activities include the research, development, and commercialization of pharmaceutical and biotechnology products. Guided by a patient-centric and science-driven approach, UCB is committed to innovation and sustainability. Through its UCB Ventures arm, it invests in pioneering technologies and companies with the potential to transform patient care. The company also offers personalized support services to patients and healthcare professionals during their treatment journey with a UCB medicine.

Recent filings

Filing Released Lang Actions
240607 - Acquisition of own shares_ENG.pdf
Transaction in Own Shares Classification · 100% confidence The document is titled "Acquisition of own shares" and explicitly discloses information regarding UCB SA/NV's "Share Repurchase Program 2024". It details the number of shares repurchased on specific dates (May 31, 2024, through June 06, 2024) and the associated transaction prices. This activity directly corresponds to the definition of a company buying back or selling its own shares. Therefore, the appropriate filing type is Transaction in Own Shares (POS). The document length is short (2782 chars) and it is a direct disclosure, not an announcement of a report.
2024-06-07 English
240607 - Acquisition actions propres_FR.pdf
Transaction in Own Shares Classification · 100% confidence The document is titled "Rachat d'actions propres" (Share Buyback) and explicitly details the transactions made by UCB SA under its 2024 Share Buyback Program between May 31, 2024, and June 6, 2024. It provides specific dates, quantities of shares repurchased, and the average price paid. This activity directly corresponds to the definition of a company buying back or selling its own shares. Therefore, the appropriate filing type is 'Transaction in Own Shares' (POS). The document length is short (2895 chars), but it is a detailed report of transactions, not just an announcement of a report's publication, making POS more specific than RPA or RNS.
2024-06-07 French
240607 - Verwerving van eigen aandelen_NL.pdf
Transaction in Own Shares Classification · 100% confidence The document is titled "Verwerving van eigen aandelen" (Acquisition of own shares) and explicitly details the number of shares repurchased, the dates (May 31, 2024, to June 6, 2024), the average price paid, and the total transaction value under the 'Aandelen Inkoopprogramma 2024' (Share Buyback Program 2024). This directly corresponds to the definition of a company reporting transactions in its own shares. The filing type code 'POS' (Transaction in Own Shares) is the most appropriate classification.
2024-06-07 Dutch
240531 - Acquisition of own shares_ENG.pdf
Transaction in Own Shares Classification · 100% confidence The document explicitly discusses the 'Acquisition of own shares' and details the number of shares repurchased on specific dates within a defined period (May 24, 2024, up to and including May 30, 2024) under the 'Share Repurchase Program 2024'. This activity directly corresponds to the definition of 'Transaction in Own Shares' (share repurchase). Therefore, the appropriate filing type code is POS.
2024-05-31 English
240531 - Acquisition actions propres_FR.pdf
Transaction in Own Shares Classification · 100% confidence The document is titled "Rachat d'actions propres" (Share Buyback) and explicitly states it is an "Information réglementée" (Regulated Information) released on May 31, 2024. It details the number of shares repurchased by UCB on Euronext Brussels between May 24 and May 30, 2024, as part of its 2024 Share Buyback Program. This activity—the company buying back its own shares—directly corresponds to the definition of 'Transaction in Own Shares'. The document length is short (2924 chars) and functions as a regulatory disclosure of this specific transaction, fitting the POS code perfectly.
2024-05-31 French
240531 - Verwerving van eigen aandelen_NL.pdf
Transaction in Own Shares Classification · 100% confidence The document is titled 'Verwerving van eigen aandelen' (Acquisition of own shares) and details the number of shares repurchased by UCB NV on Euronext Brussels between May 24, 2024, and May 30, 2024, as part of its 2024 Share Buyback Program. This activity directly corresponds to the definition of a company buying back or selling its own shares. Therefore, the appropriate filing type is 'Transaction in Own Shares' (POS). The document is a formal announcement of this transaction.
2024-05-31 Dutch

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.